EP3613852A3
(en)
|
2011-07-22 |
2020-04-22 |
President and Fellows of Harvard College |
Evaluation and improvement of nuclease cleavage specificity
|
US11021737B2
(en)
|
2011-12-22 |
2021-06-01 |
President And Fellows Of Harvard College |
Compositions and methods for analyte detection
|
GB201122458D0
(en)
|
2011-12-30 |
2012-02-08 |
Univ Wageningen |
Modified cascade ribonucleoproteins and uses thereof
|
US9637739B2
(en)
|
2012-03-20 |
2017-05-02 |
Vilnius University |
RNA-directed DNA cleavage by the Cas9-crRNA complex
|
WO2013163394A1
(en)
|
2012-04-25 |
2013-10-31 |
Regeneron Pharmaceuticals, Inc. |
Nuclease-mediated targeting with large targeting vectors
|
EP3597741A1
(en)
|
2012-04-27 |
2020-01-22 |
Duke University |
Genetic correction of mutated genes
|
DK3401400T3
(da)
|
2012-05-25 |
2019-06-03 |
Univ California |
Fremgangsmåder og sammensætninger til rna-styret mål-dna-modifikation og til rna-styret transskriptionsmodulering
|
CA2877290A1
(en)
|
2012-06-19 |
2013-12-27 |
Daniel F. Voytas |
Gene targeting in plants using dna viruses
|
JP2015527889A
(ja)
*
|
2012-07-25 |
2015-09-24 |
ザ ブロード インスティテュート, インコーポレイテッド |
誘導可能なdna結合タンパク質およびゲノム撹乱ツール、ならびにそれらの適用
|
CN110643600A
(zh)
|
2012-10-23 |
2020-01-03 |
基因工具股份有限公司 |
用于切割靶dna的***及其用途
|
JP6620018B2
(ja)
*
|
2012-12-06 |
2019-12-11 |
シグマ−アルドリッチ・カンパニー・リミテッド・ライアビリティ・カンパニーSigma−Aldrich Co., LLC |
Crisprに基づくゲノム修飾および制御
|
US8993233B2
(en)
|
2012-12-12 |
2015-03-31 |
The Broad Institute Inc. |
Engineering and optimization of systems, methods and compositions for sequence manipulation with functional domains
|
US20140186843A1
(en)
|
2012-12-12 |
2014-07-03 |
Massachusetts Institute Of Technology |
Methods, systems, and apparatus for identifying target sequences for cas enzymes or crispr-cas systems for target sequences and conveying results thereof
|
MX2015007550A
(es)
*
|
2012-12-12 |
2017-02-02 |
Broad Inst Inc |
Suministro, modificación y optimización de sistemas, métodos y composiciones para la manipulación de secuencias y aplicaciones terapéuticas.
|
CN105658796B
(zh)
*
|
2012-12-12 |
2021-10-26 |
布罗德研究所有限公司 |
用于序列操纵的crispr-cas组分***、方法以及组合物
|
WO2014093709A1
(en)
|
2012-12-12 |
2014-06-19 |
The Broad Institute, Inc. |
Methods, models, systems, and apparatus for identifying target sequences for cas enzymes or crispr-cas systems for target sequences and conveying results thereof
|
PT2898075E
(pt)
*
|
2012-12-12 |
2016-06-16 |
Harvard College |
Manipulação e otimização de sistemas, métodos e composições de enzima melhorados para manipulação de sequências
|
US8697359B1
(en)
|
2012-12-12 |
2014-04-15 |
The Broad Institute, Inc. |
CRISPR-Cas systems and methods for altering expression of gene products
|
PT2896697E
(pt)
*
|
2012-12-12 |
2015-12-31 |
Massachusetts Inst Technology |
Engenharia de sistemas, métodos e composições guia otimizadas para a manipulação de sequências
|
WO2014093694A1
(en)
|
2012-12-12 |
2014-06-19 |
The Broad Institute, Inc. |
Crispr-cas nickase systems, methods and compositions for sequence manipulation in eukaryotes
|
EP3553174A1
(en)
|
2012-12-17 |
2019-10-16 |
President and Fellows of Harvard College |
Rna-guided human genome engineering
|
US10138509B2
(en)
|
2013-03-12 |
2018-11-27 |
President And Fellows Of Harvard College |
Method for generating a three-dimensional nucleic acid containing matrix
|
EP2971167B1
(en)
|
2013-03-14 |
2019-07-31 |
Caribou Biosciences, Inc. |
Compositions and methods of nucleic acid-targeting nucleic acids
|
CA2906747A1
(en)
*
|
2013-03-15 |
2014-09-18 |
Regents Of The University Of Minnesota |
Engineering plant genomes using crispr/cas systems
|
CN105518146B
(zh)
*
|
2013-04-04 |
2022-07-15 |
哈佛学院校长同事会 |
利用CRISPR/Cas***的基因组编辑的治疗性用途
|
CN111500630A
(zh)
|
2013-04-16 |
2020-08-07 |
瑞泽恩制药公司 |
大鼠基因组的靶向修饰
|
US20160186208A1
(en)
*
|
2013-04-16 |
2016-06-30 |
Whitehead Institute For Biomedical Research |
Methods of Mutating, Modifying or Modulating Nucleic Acid in a Cell or Nonhuman Mammal
|
WO2014186686A2
(en)
*
|
2013-05-17 |
2014-11-20 |
Two Blades Foundation |
Targeted mutagenesis and genome engineering in plants using rna-guided cas nucleases
|
CA2913865C
(en)
*
|
2013-05-29 |
2022-07-19 |
Cellectis |
A method for producing precise dna cleavage using cas9 nickase activity
|
KR102282990B1
(ko)
|
2013-06-04 |
2021-07-28 |
프레지던트 앤드 펠로우즈 오브 하바드 칼리지 |
Rna-가이드된 전사 조절
|
US20140356956A1
(en)
|
2013-06-04 |
2014-12-04 |
President And Fellows Of Harvard College |
RNA-Guided Transcriptional Regulation
|
JP2016521561A
(ja)
|
2013-06-14 |
2016-07-25 |
セレクティス |
植物における非トランスジェニックのゲノム編集のための方法
|
EP3011029B1
(en)
|
2013-06-17 |
2019-12-11 |
The Broad Institute, Inc. |
Delivery, engineering and optimization of tandem guide systems, methods and compositions for sequence manipulation
|
EP4245853A3
(en)
|
2013-06-17 |
2023-10-18 |
The Broad Institute, Inc. |
Optimized crispr-cas double nickase systems, methods and compositions for sequence manipulation
|
JP6702858B2
(ja)
|
2013-06-17 |
2020-06-03 |
ザ・ブロード・インスティテュート・インコーポレイテッド |
ウイルス成分を使用して障害および疾患をターゲティングするためのCRISPR−Cas系および組成物の送達、使用および治療上の適用
|
AU2014281028B2
(en)
|
2013-06-17 |
2020-09-10 |
Massachusetts Institute Of Technology |
Delivery and use of the CRISPR-Cas systems, vectors and compositions for hepatic targeting and therapy
|
EP3725885A1
(en)
|
2013-06-17 |
2020-10-21 |
The Broad Institute, Inc. |
Functional genomics using crispr-cas systems, compositions methods, screens and applications thereof
|
EP4166669A1
(en)
*
|
2013-07-09 |
2023-04-19 |
President and Fellows of Harvard College |
Multiplex rna-guided genome engineering
|
JP2016528890A
(ja)
|
2013-07-09 |
2016-09-23 |
プレジデント アンド フェローズ オブ ハーバード カレッジ |
CRISPR/Cas系を用いるゲノム編集の治療用の使用
|
US10563225B2
(en)
|
2013-07-26 |
2020-02-18 |
President And Fellows Of Harvard College |
Genome engineering
|
US20150044192A1
(en)
|
2013-08-09 |
2015-02-12 |
President And Fellows Of Harvard College |
Methods for identifying a target site of a cas9 nuclease
|
WO2015023982A1
(en)
|
2013-08-16 |
2015-02-19 |
Massachusetts Institute Of Technology |
Selective delivery of material to cells
|
WO2015026887A1
(en)
|
2013-08-22 |
2015-02-26 |
E. I. Du Pont De Nemours And Company |
A soybean u6 polymerase iii promoter and methods of use
|
US9359599B2
(en)
|
2013-08-22 |
2016-06-07 |
President And Fellows Of Harvard College |
Engineered transcription activator-like effector (TALE) domains and uses thereof
|
US9228207B2
(en)
|
2013-09-06 |
2016-01-05 |
President And Fellows Of Harvard College |
Switchable gRNAs comprising aptamers
|
US9322037B2
(en)
|
2013-09-06 |
2016-04-26 |
President And Fellows Of Harvard College |
Cas9-FokI fusion proteins and uses thereof
|
US9737604B2
(en)
|
2013-09-06 |
2017-08-22 |
President And Fellows Of Harvard College |
Use of cationic lipids to deliver CAS9
|
ES2681622T3
(es)
|
2013-09-18 |
2018-09-14 |
Kymab Limited |
Métodos, células y organismos
|
WO2015065964A1
(en)
|
2013-10-28 |
2015-05-07 |
The Broad Institute Inc. |
Functional genomics using crispr-cas systems, compositions, methods, screens and applications thereof
|
WO2015066119A1
(en)
|
2013-10-30 |
2015-05-07 |
North Carolina State University |
Compositions and methods related to a type-ii crispr-cas system in lactobacillus buchneri
|
US9834791B2
(en)
|
2013-11-07 |
2017-12-05 |
Editas Medicine, Inc. |
CRISPR-related methods and compositions with governing gRNAS
|
US10787684B2
(en)
*
|
2013-11-19 |
2020-09-29 |
President And Fellows Of Harvard College |
Large gene excision and insertion
|
RS58159B1
(sr)
|
2013-12-11 |
2019-03-29 |
Regeneron Pharma |
Postupci i kompozicije za ciljanu modifikaciju genoma
|
US9546384B2
(en)
|
2013-12-11 |
2017-01-17 |
Regeneron Pharmaceuticals, Inc. |
Methods and compositions for the targeted modification of a mouse genome
|
EP3080271B1
(en)
|
2013-12-12 |
2020-02-12 |
The Broad Institute, Inc. |
Systems, methods and compositions for sequence manipulation with optimized functional crispr-cas systems
|
SG10201804973TA
(en)
|
2013-12-12 |
2018-07-30 |
Broad Inst Inc |
Compositions and Methods of Use of Crispr-Cas Systems in Nucleotide Repeat Disorders
|
US9068179B1
(en)
|
2013-12-12 |
2015-06-30 |
President And Fellows Of Harvard College |
Methods for correcting presenilin point mutations
|
CN111206032A
(zh)
|
2013-12-12 |
2020-05-29 |
布罗德研究所有限公司 |
用于基因组编辑的crispr-cas***和组合物的递送、用途和治疗应用
|
WO2015089364A1
(en)
|
2013-12-12 |
2015-06-18 |
The Broad Institute Inc. |
Crystal structure of a crispr-cas system, and uses thereof
|
CN105899657A
(zh)
|
2013-12-12 |
2016-08-24 |
布罗德研究所有限公司 |
用于改变基因产物表达的crispr-cas***和方法、结构信息以及诱导型模块化cas酶
|
US10787654B2
(en)
|
2014-01-24 |
2020-09-29 |
North Carolina State University |
Methods and compositions for sequence guiding Cas9 targeting
|
MX2016010285A
(es)
|
2014-02-11 |
2017-01-11 |
Univ Colorado Regents |
Ingenieria genetica multiplexada habilitada por crispr.
|
RU2016136977A
(ru)
|
2014-02-18 |
2018-03-20 |
Дьюк Юниверсити |
Композиции для инактивации репликации вируса и способы их получения и применения
|
CN106232803A
(zh)
|
2014-02-27 |
2016-12-14 |
孟山都技术公司 |
用于定点基因组修饰的组合物和方法
|
WO2015134812A1
(en)
|
2014-03-05 |
2015-09-11 |
Editas Medicine, Inc. |
Crispr/cas-related methods and compositions for treating usher syndrome and retinitis pigmentosa
|
DK3116997T3
(da)
|
2014-03-10 |
2019-08-19 |
Editas Medicine Inc |
Crispr/cas-relaterede fremgangsmåder og sammensætninger til behandling af lebers kongenitale amaurose 10 (lca10)
|
US11339437B2
(en)
|
2014-03-10 |
2022-05-24 |
Editas Medicine, Inc. |
Compositions and methods for treating CEP290-associated disease
|
US11141493B2
(en)
|
2014-03-10 |
2021-10-12 |
Editas Medicine, Inc. |
Compositions and methods for treating CEP290-associated disease
|
US11242525B2
(en)
|
2014-03-26 |
2022-02-08 |
Editas Medicine, Inc. |
CRISPR/CAS-related methods and compositions for treating sickle cell disease
|
CN106460003A
(zh)
|
2014-04-08 |
2017-02-22 |
北卡罗来纳州立大学 |
用于使用crispr相关基因rna引导阻遏转录的方法和组合物
|
EP3152221A4
(en)
*
|
2014-05-20 |
2018-01-24 |
Regents of the University of Minnesota |
Method for editing a genetic sequence
|
US20170191123A1
(en)
*
|
2014-05-28 |
2017-07-06 |
Toolgen Incorporated |
Method for Sensitive Detection of Target DNA Using Target-Specific Nuclease
|
EP3151846A4
(en)
|
2014-06-05 |
2017-12-27 |
Sangamo BioSciences, Inc. |
Methods and compositions for nuclease design
|
CN113215196A
(zh)
|
2014-06-06 |
2021-08-06 |
瑞泽恩制药公司 |
用于修饰所靶向基因座的方法和组合物
|
WO2015191693A2
(en)
*
|
2014-06-10 |
2015-12-17 |
Massachusetts Institute Of Technology |
Method for gene editing
|
AU2015274367B2
(en)
|
2014-06-13 |
2020-11-26 |
Beth Israel Deaconess Medical Center, Inc. |
Products and methods to isolate mitochondria
|
SI3354732T1
(sl)
|
2014-06-23 |
2020-07-31 |
Regeneron Pharmaceuticals, Inc. |
Z nukleazo posredovan DNA sklop
|
US20150376587A1
(en)
*
|
2014-06-25 |
2015-12-31 |
Caribou Biosciences, Inc. |
RNA Modification to Engineer Cas9 Activity
|
WO2015200555A2
(en)
*
|
2014-06-25 |
2015-12-30 |
Caribou Biosciences, Inc. |
Rna modification to engineer cas9 activity
|
HUE041584T2
(hu)
|
2014-06-26 |
2019-05-28 |
Regeneron Pharma |
Célzott genetikai módosítások és alkalmazási módszerek és készítmények
|
US10676754B2
(en)
|
2014-07-11 |
2020-06-09 |
E I Du Pont De Nemours And Company |
Compositions and methods for producing plants resistant to glyphosate herbicide
|
EP3169776A4
(en)
*
|
2014-07-14 |
2018-07-04 |
The Regents of The University of California |
Crispr/cas transcriptional modulation
|
SG11201702066UA
(en)
*
|
2014-07-21 |
2017-04-27 |
Illumina Inc |
Polynucleotide enrichment using crispr-cas systems
|
AU2015298571B2
(en)
|
2014-07-30 |
2020-09-03 |
President And Fellows Of Harvard College |
Cas9 proteins including ligand-dependent inteins
|
EP4194557A1
(en)
|
2014-08-06 |
2023-06-14 |
Institute for Basic Science |
Genome editing using campylobacter jejuni crispr/cas system-derived rgen
|
CN106536721B
(zh)
*
|
2014-08-06 |
2020-12-04 |
车医科学大学校产学协力团 |
核酸酶介导的编辑编码hla的基因所产生的免疫相容性细胞
|
WO2016025759A1
(en)
|
2014-08-14 |
2016-02-18 |
Shen Yuelei |
Dna knock-in system
|
NZ728437A
(en)
*
|
2014-08-27 |
2018-02-23 |
Caribou Biosciences Inc |
Methods for increasing cas9-mediated engineering efficiency
|
US10450584B2
(en)
|
2014-08-28 |
2019-10-22 |
North Carolina State University |
Cas9 proteins and guiding features for DNA targeting and genome editing
|
WO2016036754A1
(en)
|
2014-09-02 |
2016-03-10 |
The Regents Of The University Of California |
Methods and compositions for rna-directed target dna modification
|
CN108064129A
(zh)
|
2014-09-12 |
2018-05-22 |
纳幕尔杜邦公司 |
玉米和大豆中复合性状基因座的位点特异性整合位点的产生和使用方法
|
CN104212836A
(zh)
*
|
2014-09-18 |
2014-12-17 |
东华大学 |
一种在哺乳动物细胞系中敲除mir-505的方法
|
WO2016061374A1
(en)
|
2014-10-15 |
2016-04-21 |
Regeneron Pharmaceuticals, Inc. |
Methods and compositions for generating or maintaining pluripotent cells
|
JP6612340B2
(ja)
|
2014-10-15 |
2019-11-27 |
セージ サイエンス, インコーポレイテッド |
核酸の自動化された加工処理および電気泳動による試料調製のための装置、方法およびシステム
|
RU2739794C2
(ru)
|
2014-10-31 |
2020-12-28 |
Массачусетс Инститьют Оф Текнолоджи |
Доставка биомолекул в клетки иммунной системы
|
CN107406838A
(zh)
*
|
2014-11-06 |
2017-11-28 |
纳幕尔杜邦公司 |
Rna引导的内切核酸酶向细胞中的肽介导的递送
|
CA2963820A1
(en)
*
|
2014-11-07 |
2016-05-12 |
Editas Medicine, Inc. |
Methods for improving crispr/cas-mediated genome-editing
|
JP6621820B2
(ja)
*
|
2014-11-14 |
2019-12-18 |
インスティチュート フォー ベーシック サイエンスInstitute For Basic Science |
ゲノムでプログラマブルヌクレアーゼの非標的位置を検出する方法
|
US11352666B2
(en)
|
2014-11-14 |
2022-06-07 |
Institute For Basic Science |
Method for detecting off-target sites of programmable nucleases in a genome
|
PT3221457T
(pt)
|
2014-11-21 |
2019-06-27 |
Regeneron Pharma |
Métodos e composições para modificação genética visada através da utilização de arn guia emparelhados
|
JP7068821B2
(ja)
|
2014-12-03 |
2022-05-17 |
アジレント・テクノロジーズ・インク |
化学修飾を有するガイドrna
|
KR102656470B1
(ko)
|
2014-12-10 |
2024-04-09 |
리전츠 오브 더 유니버스티 오브 미네소타 |
질환을 치료하기 위한 유전적으로 변형된 세포, 조직 및 장기
|
WO2016094867A1
(en)
|
2014-12-12 |
2016-06-16 |
The Broad Institute Inc. |
Protected guide rnas (pgrnas)
|
CN107667171A
(zh)
*
|
2014-12-16 |
2018-02-06 |
丹尼斯科美国公司 |
真菌基因组修饰***及使用方法
|
EP3234133B1
(en)
*
|
2014-12-18 |
2020-11-11 |
Integrated DNA Technologies, Inc. |
Crispr-based compositions and methods of use
|
EP3234111A1
(en)
|
2014-12-19 |
2017-10-25 |
Regeneron Pharmaceuticals, Inc. |
Stem cells for modeling type 2 diabetes
|
RU2707137C2
(ru)
|
2014-12-19 |
2019-11-22 |
Регенерон Фармасьютикалз, Инк. |
Способы и композиции для нацеленной генетической модификации посредством одноэтапного множественного нацеливания
|
CA2971626A1
(en)
*
|
2015-01-12 |
2016-07-21 |
Massachusetts Institute Of Technology |
Gene editing through microfluidic delivery
|
EA038896B1
(ru)
*
|
2015-03-16 |
2021-11-03 |
Институт Генетики И Биологии Развития Академии Наук Китая |
Способ осуществления сайт-направленной модификации растительных геномов с использованием ненаследуемых материалов
|
WO2016150855A1
(en)
*
|
2015-03-20 |
2016-09-29 |
Danmarks Tekniske Universitet |
Crispr/cas9 based engineering of actinomycetal genomes
|
US20160281111A1
(en)
*
|
2015-03-26 |
2016-09-29 |
Editas Medicine, Inc. |
Crispr/cas-mediated gene conversion
|
CN107567499A
(zh)
|
2015-03-27 |
2018-01-09 |
纳幕尔杜邦公司 |
大豆u6核小rna基因启动子及其在植物小rna基因的组成型表达中的用途
|
AU2016246450B2
(en)
|
2015-04-06 |
2022-03-17 |
Agilent Technologies, Inc. |
Chemically modified guide RNAs for CRISPR/Cas-mediated gene regulation
|
AU2016253150B2
(en)
|
2015-04-24 |
2022-04-21 |
Editas Medicine, Inc. |
Evaluation of Cas9 molecule/guide RNA molecule complexes
|
EP3294896A1
(en)
|
2015-05-11 |
2018-03-21 |
Editas Medicine, Inc. |
Optimized crispr/cas9 systems and methods for gene editing in stem cells
|
KR101785847B1
(ko)
|
2015-05-12 |
2017-10-17 |
연세대학교 산학협력단 |
선형 이중가닥 DNA를 활용한 CRISPR/Cas9 시스템을 이용한 표적 유전체 교정
|
EP3095870A1
(en)
|
2015-05-19 |
2016-11-23 |
Kws Saat Se |
Methods for the in planta transformation of plants and manufacturing processes and products based and obtainable therefrom
|
JP2018516563A
(ja)
|
2015-05-29 |
2018-06-28 |
ノース カロライナ ステート ユニバーシティNorth Carolina State University |
Crispr核酸を用いて、細菌、古細菌、藻類、および、酵母をスクリーニングする方法
|
EP3303585A4
(en)
|
2015-06-03 |
2018-10-31 |
Board of Regents of the University of Nebraska |
Dna editing using single-stranded dna
|
AU2016276702B2
(en)
|
2015-06-09 |
2022-07-28 |
Editas Medicine, Inc. |
CRISPR/CAS-related methods and compositions for improving transplantation
|
WO2016205276A1
(en)
|
2015-06-15 |
2016-12-22 |
North Carolina State University |
Methods and compositions for efficient delivery of nucleic acids and rna-based antimicrobials
|
WO2016205759A1
(en)
|
2015-06-18 |
2016-12-22 |
The Broad Institute Inc. |
Engineering and optimization of systems, methods, enzymes and guide scaffolds of cas9 orthologs and variants for sequence manipulation
|
CN108290933A
(zh)
|
2015-06-18 |
2018-07-17 |
布罗德研究所有限公司 |
降低脱靶效应的crispr酶突变
|
WO2017004261A1
(en)
|
2015-06-29 |
2017-01-05 |
Ionis Pharmaceuticals, Inc. |
Modified crispr rna and modified single crispr rna and uses thereof
|
CA2988996A1
(en)
|
2015-07-09 |
2017-01-12 |
Massachusetts Institute Of Technology |
Delivery of materials to anucleate cells
|
EP3329001B1
(en)
*
|
2015-07-28 |
2021-09-22 |
Danisco US Inc. |
Genome editing systems and methods of use
|
EP4339287A3
(en)
|
2015-07-31 |
2024-05-22 |
Regents Of The University Of Minnesota |
Modified cells and methods of therapy
|
US9580727B1
(en)
|
2015-08-07 |
2017-02-28 |
Caribou Biosciences, Inc. |
Compositions and methods of engineered CRISPR-Cas9 systems using split-nexus Cas9-associated polynucleotides
|
WO2017027910A1
(en)
|
2015-08-14 |
2017-02-23 |
The University Of Sydney |
Connexin 45 inhibition for therapy
|
CA2996001A1
(en)
|
2015-08-25 |
2017-03-02 |
Duke University |
Compositions and methods of improving specificity in genomic engineering using rna-guided endonucleases
|
WO2017041051A1
(en)
|
2015-09-04 |
2017-03-09 |
Sqz Biotechnologies Company |
Intracellular delivery of biomolecules to cells comprising a cell wall
|
EP3352795B1
(en)
*
|
2015-09-21 |
2020-08-12 |
The Regents of The University of California |
Compositions and methods for target nucleic acid modification
|
AU2016326711B2
(en)
|
2015-09-24 |
2022-11-03 |
Editas Medicine, Inc. |
Use of exonucleases to improve CRISPR/Cas-mediated genome editing
|
WO2017058751A1
(en)
|
2015-09-28 |
2017-04-06 |
North Carolina State University |
Methods and compositions for sequence specific antimicrobials
|
BR112018007070A2
(pt)
*
|
2015-10-06 |
2019-06-04 |
Aict |
método, composição e kit para a preparação de uma planta a partir de um protoplasto, planta regenerada e composição para clivagem de dna
|
EP4089175A1
(en)
|
2015-10-13 |
2022-11-16 |
Duke University |
Genome engineering with type i crispr systems in eukaryotic cells
|
MX2018004808A
(es)
*
|
2015-10-20 |
2018-08-01 |
Pioneer Hi Bred Int |
Funcion restauradora para un producto genico no funcional mediante sistemas cas guiados y metodos de uso.
|
ES2699848T3
(es)
|
2015-10-23 |
2019-02-13 |
Caribou Biosciences Inc |
Acido nucleico CRISPR clase 2 de tipo cruzado modificado que se dirige a ácidos nucleicos
|
CN108513575A
(zh)
|
2015-10-23 |
2018-09-07 |
哈佛大学的校长及成员们 |
核碱基编辑器及其用途
|
GB2559526B
(en)
|
2015-11-03 |
2021-02-17 |
Harvard College |
Method and apparatus for volumetric imaging of a three-dimensional nucleic acid containing matrix
|
KR101885901B1
(ko)
*
|
2015-11-13 |
2018-08-07 |
기초과학연구원 |
5' 말단의 인산기가 제거된 rna를 포함하는 리보핵산단백질 전달용 조성물
|
US11542495B2
(en)
|
2015-11-20 |
2023-01-03 |
Sage Science, Inc. |
Preparative electrophoretic method for targeted purification of genomic DNA fragments
|
WO2017095946A1
(en)
|
2015-11-30 |
2017-06-08 |
Flagship Pioneering, Inc. |
Methods and compositions relating to chondrisomes
|
CN106811479B
(zh)
*
|
2015-11-30 |
2019-10-25 |
中国农业科学院作物科学研究所 |
利用CRISPR/Cas9***定点修饰ALS基因获得抗除草剂水稻的***及其应用
|
US9771600B2
(en)
|
2015-12-04 |
2017-09-26 |
Caribou Biosciences, Inc. |
Engineered nucleic acid-targeting nucleic acids
|
CN106845151B
(zh)
*
|
2015-12-07 |
2019-03-26 |
中国农业大学 |
CRISPR-Cas9***sgRNA作用靶点的筛选方法及装置
|
WO2017099494A1
(ko)
*
|
2015-12-08 |
2017-06-15 |
기초과학연구원 |
Cpf1을 포함하는 유전체 교정용 조성물 및 그 용도
|
WO2017112620A1
(en)
|
2015-12-22 |
2017-06-29 |
North Carolina State University |
Methods and compositions for delivery of crispr based antimicrobials
|
KR20180095719A
(ko)
|
2016-01-11 |
2018-08-27 |
더 보드 어브 트러스티스 어브 더 리랜드 스탠포드 주니어 유니버시티 |
키메라 단백질 및 면역요법 방법
|
US9856497B2
(en)
|
2016-01-11 |
2018-01-02 |
The Board Of Trustee Of The Leland Stanford Junior University |
Chimeric proteins and methods of regulating gene expression
|
SG11201805993UA
(en)
*
|
2016-01-15 |
2018-08-30 |
Jackson Lab |
Genetically modified non-human mammals by multi-cycle electroporation of cas9 protein
|
EP3433363A1
(en)
|
2016-03-25 |
2019-01-30 |
Editas Medicine, Inc. |
Genome editing systems comprising repair-modulating enzyme molecules and methods of their use
|
US11512311B2
(en)
|
2016-03-25 |
2022-11-29 |
Editas Medicine, Inc. |
Systems and methods for treating alpha 1-antitrypsin (A1AT) deficiency
|
TWI773666B
(zh)
*
|
2016-03-30 |
2022-08-11 |
美商英特利亞醫療公司 |
Crispr/cas 組分之脂質奈米粒子調配物
|
US11236313B2
(en)
|
2016-04-13 |
2022-02-01 |
Editas Medicine, Inc. |
Cas9 fusion molecules, gene editing systems, and methods of use thereof
|
CN116200465A
(zh)
|
2016-04-25 |
2023-06-02 |
哈佛学院董事及会员团体 |
用于原位分子检测的杂交链反应方法
|
CN107326046A
(zh)
*
|
2016-04-28 |
2017-11-07 |
上海邦耀生物科技有限公司 |
一种提高外源基因同源重组效率的方法
|
RU2021106817A
(ru)
|
2016-05-20 |
2021-04-06 |
Регенерон Фармасьютикалс, Инк. |
Способы преодоления иммунологической толерантности с использованием множества направляющих рнк
|
JP2019521659A
(ja)
*
|
2016-05-27 |
2019-08-08 |
アーディジェン, エルエルシー |
ゲノム編集分子の細胞内送達のためのペプチドおよびナノ粒子
|
EP3604527B1
(en)
|
2016-06-02 |
2021-05-12 |
Sigma-Aldrich Co., LLC |
Using programmable dna binding proteins to enhance targeted genome modification
|
US10767175B2
(en)
|
2016-06-08 |
2020-09-08 |
Agilent Technologies, Inc. |
High specificity genome editing using chemically modified guide RNAs
|
US20190177710A1
(en)
*
|
2016-06-15 |
2019-06-13 |
Toolgen Incorporated |
Method For Screening Target Specific Nuclease Using Multi-Target System Of On-Target And Off-Target And Use Thereof
|
WO2017216771A2
(en)
*
|
2016-06-17 |
2017-12-21 |
Genesis Technologies Limited |
Crispr-cas system, materials and methods
|
JP7267013B2
(ja)
|
2016-06-17 |
2023-05-01 |
ザ・ブロード・インスティテュート・インコーポレイテッド |
Vi型crisprオルソログ及び系
|
IL263595B2
(en)
*
|
2016-06-20 |
2023-11-01 |
Keygene Nv |
A method for targeted modification of DNA in plant cells
|
AU2017280353B2
(en)
|
2016-06-24 |
2021-11-11 |
Inscripta, Inc. |
Methods for generating barcoded combinatorial libraries
|
EA201990214A1
(ru)
*
|
2016-07-05 |
2019-11-29 |
|
Композиции на основе crispr/cas9 и способы лечения рака
|
BR112019000430A2
(pt)
|
2016-07-13 |
2019-07-09 |
Dsm Ip Assets Bv |
sistema crispr-cas para uma célula hospedeira de algas
|
US20190309283A1
(en)
*
|
2016-07-19 |
2019-10-10 |
Biodynamics Laboratory, Inc. |
Method for preparing long-chain single-stranded dna
|
KR101961332B1
(ko)
|
2016-07-28 |
2019-03-22 |
기초과학연구원 |
Cas9 단백질 및 가이드 RNA를 포함하는 안질환 치료용 약학 조성물
|
CN109803530A
(zh)
|
2016-07-29 |
2019-05-24 |
瑞泽恩制药公司 |
包含引起c-截短的原纤维蛋白-1表达的突变的小鼠
|
BR112019001887A2
(pt)
|
2016-08-02 |
2019-07-09 |
Editas Medicine Inc |
composições e métodos para o tratamento de doença associada a cep290
|
US11078481B1
(en)
|
2016-08-03 |
2021-08-03 |
KSQ Therapeutics, Inc. |
Methods for screening for cancer targets
|
WO2018027078A1
(en)
|
2016-08-03 |
2018-02-08 |
President And Fellows Of Harard College |
Adenosine nucleobase editors and uses thereof
|
CA3033327A1
(en)
|
2016-08-09 |
2018-02-15 |
President And Fellows Of Harvard College |
Programmable cas9-recombinase fusion proteins and uses thereof
|
KR101710026B1
(ko)
|
2016-08-10 |
2017-02-27 |
주식회사 무진메디 |
Cas9 단백질 및 가이드 RNA의 혼성체를 함유하는 나노 리포좀 전달체 조성물
|
WO2018039438A1
(en)
|
2016-08-24 |
2018-03-01 |
President And Fellows Of Harvard College |
Incorporation of unnatural amino acids into proteins using base editing
|
KR101856345B1
(ko)
*
|
2016-08-24 |
2018-06-20 |
경상대학교산학협력단 |
CRISPR/Cas9 시스템을 이용하여 APOBEC3H 및 APOBEC3CH 이중-넉아웃 고양이를 제조하는 방법
|
US11078483B1
(en)
|
2016-09-02 |
2021-08-03 |
KSQ Therapeutics, Inc. |
Methods for measuring and improving CRISPR reagent function
|
US20190225974A1
(en)
|
2016-09-23 |
2019-07-25 |
BASF Agricultural Solutions Seed US LLC |
Targeted genome optimization in plants
|
WO2018068053A2
(en)
|
2016-10-07 |
2018-04-12 |
Integrated Dna Technologies, Inc. |
S. pyogenes cas9 mutant genes and polypeptides encoded by same
|
US11242542B2
(en)
|
2016-10-07 |
2022-02-08 |
Integrated Dna Technologies, Inc. |
S. pyogenes Cas9 mutant genes and polypeptides encoded by same
|
KR101997116B1
(ko)
|
2016-10-14 |
2019-07-05 |
연세대학교 산학협력단 |
Kras 유전자에 상보적인 가이드 rna 및 이의 용도
|
KR20240007715A
(ko)
|
2016-10-14 |
2024-01-16 |
프레지던트 앤드 펠로우즈 오브 하바드 칼리지 |
핵염기 에디터의 aav 전달
|
EP3529359B1
(en)
|
2016-10-18 |
2023-12-13 |
Regents of the University of Minnesota |
Tumor infiltrating lymphocytes for use in therapy
|
CN109906030B
(zh)
|
2016-11-04 |
2022-03-18 |
安健基因公司 |
用于产生仅重链抗体的经基因修饰的非人动物和方法
|
WO2018085693A1
(en)
|
2016-11-04 |
2018-05-11 |
Inari Agriculture, Inc. |
Novel plant cells, plants, and seeds
|
US20190276503A1
(en)
*
|
2016-11-14 |
2019-09-12 |
Toolgen Incorporated |
Artificially engineered sc function control system
|
EP3545085A4
(en)
|
2016-11-22 |
2020-10-28 |
Integrated Dna Technologies, Inc. |
CRISPR / CPF1 SYSTEMS AND METHODS
|
US11293022B2
(en)
|
2016-12-12 |
2022-04-05 |
Integrated Dna Technologies, Inc. |
Genome editing enhancement
|
KR101748575B1
(ko)
*
|
2016-12-16 |
2017-06-20 |
주식회사 엠젠플러스 |
Ins 유전자 녹아웃 당뇨병 또는 당뇨병 합병증 동물모델 및 이의 제조방법
|
KR102117110B1
(ko)
*
|
2016-12-22 |
2020-05-29 |
주식회사 툴젠 |
Fad2 유전자 조작된 올레인산 강화 식물체 및 이의 제조 방법
|
WO2018117746A1
(ko)
*
|
2016-12-23 |
2018-06-28 |
기초과학연구원 |
동물 배아의 염기 교정용 조성물 및 염기 교정 방법
|
US10745677B2
(en)
|
2016-12-23 |
2020-08-18 |
President And Fellows Of Harvard College |
Editing of CCR5 receptor gene to protect against HIV infection
|
JP6994730B2
(ja)
*
|
2016-12-26 |
2022-02-04 |
独立行政法人酒類総合研究所 |
ゲノム編集タンパク質の直接導入による糸状菌ゲノム編集方法
|
US11859219B1
(en)
|
2016-12-30 |
2024-01-02 |
Flagship Pioneering Innovations V, Inc. |
Methods of altering a target nucleotide sequence with an RNA-guided nuclease and a single guide RNA
|
KR102515727B1
(ko)
*
|
2017-01-11 |
2023-03-30 |
주식회사 툴젠 |
중첩된 가이드핵산을 이용한 표적 핵산에 특정 핵산 서열을 삽입하기 위한 조성물 및 방법
|
RU2021133626A
(ru)
|
2017-01-23 |
2022-01-31 |
Регенерон Фармасьютикалз, Инк. |
Варианты hsd17b13 и их применения
|
WO2018140899A1
(en)
|
2017-01-28 |
2018-08-02 |
Inari Agriculture, Inc. |
Novel plant cells, plants, and seeds
|
TW201839136A
(zh)
|
2017-02-06 |
2018-11-01 |
瑞士商諾華公司 |
治療血色素異常症之組合物及方法
|
JP2020508693A
(ja)
*
|
2017-03-06 |
2020-03-26 |
インスティテュート フォー ベーシック サイエンスInstitute For Basic Science |
C2c1エンドヌクレアーゼを含むゲノム編集用組成物およびこれを用いたゲノム編集方法
|
EP3592853A1
(en)
|
2017-03-09 |
2020-01-15 |
President and Fellows of Harvard College |
Suppression of pain by gene editing
|
JP2020510439A
(ja)
|
2017-03-10 |
2020-04-09 |
プレジデント アンド フェローズ オブ ハーバード カレッジ |
シトシンからグアニンへの塩基編集因子
|
WO2018170184A1
(en)
|
2017-03-14 |
2018-09-20 |
Editas Medicine, Inc. |
Systems and methods for the treatment of hemoglobinopathies
|
SG11201908658TA
(en)
|
2017-03-23 |
2019-10-30 |
Harvard College |
Nucleobase editors comprising nucleic acid programmable dna binding proteins
|
WO2018187779A1
(en)
|
2017-04-07 |
2018-10-11 |
Sage Science, Inc. |
Systems and methods for detection of genetic structural variation using integrated electrophoretic dna purification
|
CA3059643A1
(en)
|
2017-04-13 |
2018-10-18 |
Cellectis |
New sequence specific reagents targeting ccr5 in primary hematopoietic cells
|
WO2018195129A1
(en)
|
2017-04-17 |
2018-10-25 |
University Of Maryland, College Park |
Embryonic cell cultures and methods of using the same
|
WO2018201086A1
(en)
|
2017-04-28 |
2018-11-01 |
Editas Medicine, Inc. |
Methods and systems for analyzing guide rna molecules
|
KR20200004382A
(ko)
*
|
2017-05-05 |
2020-01-13 |
인스티튜트 오브 제네틱스 앤드 디벨롭멘털 바이오롤지, 차이니즈 아카데미 오브 사이언시스 |
전이유전자성 마커 서열을 이용하지 않는 세포 단리 방법
|
EP3622070A2
(en)
|
2017-05-10 |
2020-03-18 |
Editas Medicine, Inc. |
Crispr/rna-guided nuclease systems and methods
|
US11560566B2
(en)
|
2017-05-12 |
2023-01-24 |
President And Fellows Of Harvard College |
Aptazyme-embedded guide RNAs for use with CRISPR-Cas9 in genome editing and transcriptional activation
|
EP3635102A1
(en)
|
2017-06-05 |
2020-04-15 |
Regeneron Pharmaceuticals, Inc. |
B4galt1 variants and uses thereof
|
CN108977442B
(zh)
*
|
2017-06-05 |
2023-01-06 |
广州市锐博生物科技有限公司 |
用于dna编辑的***及其应用
|
WO2018227114A1
(en)
|
2017-06-09 |
2018-12-13 |
Editas Medicine, Inc. |
Engineered cas9 nucleases
|
JP2020524993A
(ja)
|
2017-06-13 |
2020-08-27 |
フラッグシップ パイオニアリング イノベーションズ ブイ, インコーポレイテッド |
クロンを含む組成物及びその使用
|
AU2018283405A1
(en)
|
2017-06-15 |
2020-01-16 |
The Regents Of The University Of California |
Targeted non-viral DNA insertions
|
US9982279B1
(en)
|
2017-06-23 |
2018-05-29 |
Inscripta, Inc. |
Nucleic acid-guided nucleases
|
US10011849B1
(en)
|
2017-06-23 |
2018-07-03 |
Inscripta, Inc. |
Nucleic acid-guided nucleases
|
JP2020530307A
(ja)
|
2017-06-30 |
2020-10-22 |
インティマ・バイオサイエンス,インコーポレーテッド |
遺伝子治療のためのアデノ随伴ウイルスベクター
|
EP3652312A1
(en)
|
2017-07-14 |
2020-05-20 |
Editas Medicine, Inc. |
Systems and methods for targeted integration and genome editing and detection thereof using integrated priming sites
|
CN107488710B
(zh)
*
|
2017-07-14 |
2020-09-22 |
上海吐露港生物科技有限公司 |
一种Cas蛋白的用途及靶标核酸分子的检测方法和试剂盒
|
EP3655961A4
(en)
*
|
2017-07-17 |
2021-09-01 |
Massachusetts Institute of Technology |
CELL ATLAS OF HEALTHY AND DISEASED BARRIER TISSUE
|
US11732274B2
(en)
|
2017-07-28 |
2023-08-22 |
President And Fellows Of Harvard College |
Methods and compositions for evolving base editors using phage-assisted continuous evolution (PACE)
|
US20190032156A1
(en)
|
2017-07-31 |
2019-01-31 |
Regeneron Pharmaceuticals, Inc. |
Methods and compositions for assessing crispr/cas-induced recombination with an exogenous donor nucleic acid in vivo
|
SG11201912235PA
(en)
|
2017-07-31 |
2020-01-30 |
Regeneron Pharma |
Cas-transgenic mouse embryonic stem cells and mice and uses thereof
|
MX2020001177A
(es)
|
2017-07-31 |
2020-09-25 |
Regeneron Pharma |
Animales no humanos reporteros de crispr y usos de los mismos.
|
US11897920B2
(en)
|
2017-08-04 |
2024-02-13 |
Peking University |
Tale RVD specifically recognizing DNA base modified by methylation and application thereof
|
EP3666898A4
(en)
|
2017-08-08 |
2021-03-24 |
Peking University |
GENE INACTIVATION PROCESS
|
US11319532B2
(en)
|
2017-08-30 |
2022-05-03 |
President And Fellows Of Harvard College |
High efficiency base editors comprising Gam
|
US11713452B2
(en)
|
2017-09-08 |
2023-08-01 |
University Of North Texas Health Science Center |
Engineered CAS9 variants
|
WO2019052577A1
(zh)
|
2017-09-18 |
2019-03-21 |
博雅辑因(北京)生物科技有限公司 |
一种基因编辑t细胞及其用途
|
KR102670361B1
(ko)
*
|
2017-09-28 |
2024-05-29 |
주식회사 툴젠 |
유전자 발현 조절을 위한 인위적인 게놈 조작
|
US11572574B2
(en)
|
2017-09-28 |
2023-02-07 |
Toolgen Incorporated |
Artificial genome manipulation for gene expression regulation
|
IL311278A
(en)
*
|
2017-09-29 |
2024-05-01 |
Intellia Therapeutics Inc |
Polynucleotides, preparations, and methods for genome editing
|
MX2020003589A
(es)
|
2017-09-29 |
2020-07-22 |
Regeneron Pharma |
Animales no humanos que comprenden un locus ttr humanizado y metodos de uso.
|
KR102207352B1
(ko)
*
|
2017-09-29 |
2021-01-26 |
서울대학교산학협력단 |
Klotho 유전자 넉아웃 질환모델 동물 및 이의 용도
|
CN111757937A
(zh)
|
2017-10-16 |
2020-10-09 |
布罗德研究所股份有限公司 |
腺苷碱基编辑器的用途
|
KR102503130B1
(ko)
|
2017-10-27 |
2023-02-24 |
더 리전트 오브 더 유니버시티 오브 캘리포니아 |
내인성 t 세포 수용체의 표적화된 대체
|
CN109722415B
(zh)
|
2017-10-27 |
2021-01-26 |
博雅辑因(北京)生物科技有限公司 |
一种造血干细胞的培养组合物、培养基以及造血干细胞的培养方法
|
CN108192956B
(zh)
*
|
2017-11-17 |
2021-06-01 |
东南大学 |
一种基于Cas9核酸酶的DNA检测分析方法及其应用
|
EP3715461A4
(en)
|
2017-11-21 |
2021-09-08 |
Genkore Co. Ltd. |
GENOMIC EDITION COMPOSITION USING A CRISPR / CPF1 SYSTEM AND ITS USE
|
AU2019207409B2
(en)
|
2018-01-12 |
2023-02-23 |
Basf Se |
Gene underlying the number of spikelets per spike qtl in wheat on chromosome 7a
|
JP7075170B2
(ja)
*
|
2018-01-23 |
2022-05-25 |
インスティチュート フォー ベーシック サイエンス |
延長された単一ガイドrna及びその用途
|
US11926835B1
(en)
|
2018-01-29 |
2024-03-12 |
Inari Agriculture Technology, Inc. |
Methods for efficient tomato genome editing
|
WO2019156475A1
(ko)
*
|
2018-02-06 |
2019-08-15 |
주식회사 진씨커 |
돌연변이 세포 유리 유전자 분리 키트 및 이를 이용한 돌연변이 세포 유리 유전자 분리 방법
|
KR102086689B1
(ko)
*
|
2018-02-06 |
2020-03-09 |
주식회사 진씨커 |
돌연변이 세포 유리 유전자 분리 키트 및 이를 이용한 돌연변이 세포 유리 유전자 분리 방법
|
CA3089331A1
(en)
|
2018-03-19 |
2019-09-26 |
Regeneron Pharmaceuticals, Inc. |
Transcription modulation in animals using crispr/cas systems
|
BR112020021229A2
(pt)
|
2018-04-19 |
2021-02-02 |
The Regents Of The University Of California |
composições e métodos para edição de genes
|
WO2019206233A1
(zh)
*
|
2018-04-25 |
2019-10-31 |
中国农业大学 |
一种RNA编辑的CRISPR/Cas效应蛋白及***
|
EP3794130A4
(en)
|
2018-05-16 |
2022-07-27 |
Synthego Corporation |
METHODS AND SYSTEMS FOR DESIGN AND USE OF GUIDE RNA
|
US11866719B1
(en)
|
2018-06-04 |
2024-01-09 |
Inari Agriculture Technology, Inc. |
Heterologous integration of regulatory elements to alter gene expression in wheat cells and wheat plants
|
KR102035654B1
(ko)
*
|
2018-07-23 |
2019-10-24 |
대한민국 |
항균 펩타이드를 생산하는 돌연변이 곤충 세포주 또는 이의 제조방법
|
US11459551B1
(en)
|
2018-08-31 |
2022-10-04 |
Inari Agriculture Technology, Inc. |
Compositions, systems, and methods for genome editing
|
US20220049274A1
(en)
*
|
2018-09-12 |
2022-02-17 |
Institute For Basic Science |
Composition for inducing death of cells having mutated gene, and method for inducing death of cells having mutated gene by using composition
|
EP3861120A4
(en)
|
2018-10-01 |
2023-08-16 |
North Carolina State University |
RECOMBINANT TYPE I CRISPR-CAS SYSTEM
|
KR102081962B1
(ko)
*
|
2018-10-11 |
2020-02-26 |
충남대학교 산학협력단 |
아밀로이드 전구 단백질 유전자를 절단하기 위한 조성물
|
TW202027797A
(zh)
|
2018-10-18 |
2020-08-01 |
美商英特利亞醫療公司 |
用於治療α-1抗胰蛋白酶不足的組成物及方法
|
US20200270617A1
(en)
|
2018-10-18 |
2020-08-27 |
Intellia Therapeutics, Inc. |
Compositions and methods for transgene expression from an albumin locus
|
CN113272428A
(zh)
|
2018-10-18 |
2021-08-17 |
英特利亚治疗股份有限公司 |
核酸构建体和使用方法
|
CN113260701A
(zh)
|
2018-10-18 |
2021-08-13 |
英特利亚治疗股份有限公司 |
用于表达因子ix的组合物和方法
|
CN111757889B
(zh)
*
|
2018-10-29 |
2021-05-25 |
中国农业大学 |
新型CRISPR/Cas12f酶和***
|
WO2020089448A1
(en)
*
|
2018-11-01 |
2020-05-07 |
Keygene N.V. |
Dual guide rna for crispr/cas genome editing in plants cells
|
EP3650557B1
(en)
*
|
2018-11-07 |
2021-10-20 |
Justus-Liebig-Universität Gießen |
Method for determination of restriction efficiency of endonucleases mediating double-strand breaks in dna target sequences
|
US20210324420A1
(en)
*
|
2018-11-16 |
2021-10-21 |
Osaka University |
Method for producing genome-edited cell
|
KR20200071198A
(ko)
|
2018-12-10 |
2020-06-19 |
네오이뮨텍, 인코퍼레이티드 |
Nrf2 발현 조절 기반 T 세포 항암면역치료법
|
US11166996B2
(en)
|
2018-12-12 |
2021-11-09 |
Flagship Pioneering Innovations V, Inc. |
Anellovirus compositions and methods of use
|
WO2020122195A1
(ja)
*
|
2018-12-12 |
2020-06-18 |
国立大学法人九州大学 |
ゲノム編集された細胞の製造方法
|
EP3894550A4
(en)
|
2018-12-14 |
2023-01-04 |
Pioneer Hi-Bred International, Inc. |
NEW CRISPR-CAS SYSTEMS FOR GENOME EDITING
|
AU2019403015B2
(en)
|
2018-12-20 |
2024-01-18 |
Regeneron Pharmaceuticals, Inc. |
Nuclease-mediated repeat expansion
|
GB2596660B
(en)
*
|
2019-01-07 |
2023-09-13 |
Crisp Hr Therapeutics Inc |
A non-toxic Cas9 enzyme and application thereof
|
CN109868275A
(zh)
*
|
2019-03-12 |
2019-06-11 |
中国农业大学 |
CRISPR/Cas9介导的羊FGF5基因敲除和定点整合MTNR1A基因的方法
|
ES2970541T3
(es)
|
2019-03-18 |
2024-05-29 |
Regeneron Pharma |
Plataforma de cribado CRISPR/CAS para identificar modificadores genéticos de la siembra o agregación de tau
|
AU2020241856B2
(en)
|
2019-03-18 |
2024-06-27 |
Regeneron Pharmaceuticals, Inc. |
CRISPR/Cas dropout screening platform to reveal genetic vulnerabilities associated with tau aggregation
|
DE112020001342T5
(de)
|
2019-03-19 |
2022-01-13 |
President and Fellows of Harvard College |
Verfahren und Zusammensetzungen zum Editing von Nukleotidsequenzen
|
KR20210148154A
(ko)
|
2019-04-03 |
2021-12-07 |
리제너론 파마슈티칼스 인코포레이티드 |
세이프 하버 좌위 내로의 항체 코딩 서열의 삽입을 위한 방법 및 조성물
|
CA3133360A1
(en)
|
2019-04-04 |
2020-10-08 |
Regeneron Pharmaceuticals, Inc. |
Non-human animals comprising a humanized coagulation factor 12 locus
|
WO2020206134A1
(en)
|
2019-04-04 |
2020-10-08 |
Regeneron Pharmaceuticals, Inc. |
Methods for scarless introduction of targeted modifications into targeting vectors
|
EP3964579A4
(en)
|
2019-04-30 |
2023-07-26 |
EdiGene (GuangZhou) Inc. |
METHOD OF PREDICTING THE EFFECTIVENESS OF THE TREATMENT OF HEMOGLOBINOPATHY
|
US11692197B2
(en)
|
2019-05-06 |
2023-07-04 |
Inari Agriculture Technology, Inc. |
Delivery of biological molecules to plant cells
|
US11891618B2
(en)
|
2019-06-04 |
2024-02-06 |
Regeneron Pharmaceuticals, Inc. |
Mouse comprising a humanized TTR locus with a beta-slip mutation and methods of use
|
CN111304180B
(zh)
*
|
2019-06-04 |
2023-05-26 |
山东舜丰生物科技有限公司 |
一种新的dna核酸切割酶及其应用
|
AU2020289581A1
(en)
|
2019-06-07 |
2021-11-18 |
Regeneron Pharmaceuticals, Inc. |
Non-human animals comprising a humanized albumin locus
|
JP2022536606A
(ja)
|
2019-06-14 |
2022-08-18 |
リジェネロン・ファーマシューティカルズ・インコーポレイテッド |
タウオパチーのモデル
|
EP3990633A1
(en)
|
2019-06-25 |
2022-05-04 |
Inari Agriculture Technology, Inc. |
Improved homology dependent repair genome editing
|
CN115244176A
(zh)
*
|
2019-08-19 |
2022-10-25 |
钟明宏 |
向导rna-cas蛋白复合物的缀合物
|
KR20220053671A
(ko)
|
2019-09-04 |
2022-04-29 |
에디진 인크. |
오프 타겟 평가 기반의 유전자 편집 치료의 평가 방법
|
CN114616002A
(zh)
|
2019-09-13 |
2022-06-10 |
瑞泽恩制药公司 |
使用由脂质纳米颗粒递送的crispr/cas***在动物中进行的转录调控
|
JP2022548320A
(ja)
|
2019-09-23 |
2022-11-17 |
オメガ セラピューティクス, インコーポレイテッド |
アポリポタンパク質b(apob)遺伝子発現をモジュレートするための組成物および方法
|
US11987791B2
(en)
|
2019-09-23 |
2024-05-21 |
Omega Therapeutics, Inc. |
Compositions and methods for modulating hepatocyte nuclear factor 4-alpha (HNF4α) gene expression
|
WO2021067788A1
(en)
|
2019-10-03 |
2021-04-08 |
Artisan Development Labs, Inc. |
Crispr systems with engineered dual guide nucleic acids
|
JP2023505600A
(ja)
*
|
2019-11-05 |
2023-02-09 |
ペアーワイズ プランツ サービシズ, インコーポレイテッド |
対立遺伝子のrnaにコードされたdnaの置換のための組成物および方法
|
IL292605A
(en)
|
2019-11-08 |
2022-07-01 |
Regeneron Pharma |
CRISPR and AAV strategies for the treatment of x-linked childhood retinoschisis
|
JP7448120B2
(ja)
*
|
2019-11-14 |
2024-03-12 |
国立研究開発法人農業・食品産業技術総合研究機構 |
プラズマを用いてゲノム編集酵素を植物細胞内に導入する方法
|
WO2021108363A1
(en)
|
2019-11-25 |
2021-06-03 |
Regeneron Pharmaceuticals, Inc. |
Crispr/cas-mediated upregulation of humanized ttr allele
|
WO2021108442A2
(en)
*
|
2019-11-27 |
2021-06-03 |
The Regents Of The University Of California |
Modulators of cas9 polypeptide activity and methods of use thereof
|
WO2021136415A1
(zh)
|
2019-12-30 |
2021-07-08 |
博雅辑因(北京)生物科技有限公司 |
一种纯化ucart细胞的方法与应用
|
CN114901813A
(zh)
|
2019-12-30 |
2022-08-12 |
博雅缉因(北京)生物科技有限公司 |
一种靶向t细胞淋巴瘤细胞的通用型car-t及其制备方法和应用
|
WO2021145703A1
(ko)
|
2020-01-14 |
2021-07-22 |
주식회사 툴젠 |
알츠하이머 예방 또는 치료용 약학적 조성물 및 이의 용도
|
JP2023510825A
(ja)
*
|
2020-01-14 |
2023-03-15 |
ツールゲン インコーポレイテッド |
低酸素環境下で高い適応力を有する細胞及びその用途
|
WO2021163515A1
(en)
*
|
2020-02-12 |
2021-08-19 |
Temple University - Of The Commonwealth System Of Higher Education |
Crispr-cas9 mediated disruption of alcam gene inhibits adhesion and trans-endothelial migration of myeloid cells
|
KR20210109384A
(ko)
|
2020-02-27 |
2021-09-06 |
주식회사 엘지화학 |
원형질체를 활용한 식물 유전자 교정 효율 증대 방법
|
EP4114946A1
(en)
|
2020-03-04 |
2023-01-11 |
Regeneron Pharmaceuticals, Inc. |
Methods and compositions for sensitization of tumor cells to immune therapy
|
AU2021234302A1
(en)
|
2020-03-11 |
2022-11-10 |
Omega Therapeutics, Inc. |
Compositions and methods for modulating forkhead box p3 (foxp3) gene expression
|
WO2021195079A1
(en)
|
2020-03-23 |
2021-09-30 |
Regeneron Pharmaceuticals, Inc. |
Non-human animals comprising a humanized ttr locus comprising a v30m mutation and methods of use
|
US20210319851A1
(en)
|
2020-04-03 |
2021-10-14 |
Creyon Bio, Inc. |
Oligonucleotide-based machine learning
|
EP4146804A1
(en)
|
2020-05-08 |
2023-03-15 |
The Broad Institute Inc. |
Methods and compositions for simultaneous editing of both strands of a target double-stranded nucleotide sequence
|
CN111690720B
(zh)
*
|
2020-06-16 |
2021-06-15 |
山东舜丰生物科技有限公司 |
利用修饰的单链核酸进行靶核酸检测的方法
|
WO2022120022A1
(en)
|
2020-12-02 |
2022-06-09 |
Regeneron Pharmaceuticals, Inc. |
Crispr sam biosensor cell lines and methods of use thereof
|
KR20220081949A
(ko)
*
|
2020-12-09 |
2022-06-16 |
재단법인 아산사회복지재단 |
온-타겟 활성이 유지되고 오프-타겟 활성이 감소된 가이드 rna 및 이의 용도
|
EP4267157A1
(en)
|
2020-12-23 |
2023-11-01 |
Flagship Pioneering Innovations V, Inc. |
In vitro assembly of anellovirus capsids enclosing rna
|
AU2021411521A1
(en)
|
2020-12-30 |
2023-08-03 |
Intellia Therapeutics, Inc. |
Engineered t cells
|
KR102285906B1
(ko)
*
|
2021-02-18 |
2021-08-04 |
주식회사 엔에이피 |
수생태계 교란어종 관리를 위한 큰입배스 불임 유도용 조성물
|
CA3218511A1
(en)
|
2021-05-10 |
2022-11-17 |
Sqz Biotechnologies Company |
Methods for delivering genome editing molecules to the nucleus or cytosol of a cell and uses thereof
|
KR102616916B1
(ko)
*
|
2021-05-11 |
2023-12-21 |
주식회사 애이마 |
발암성 돌연변이 유전자 검출용 가이드 rna 내지 이의 용도
|
WO2022251644A1
(en)
|
2021-05-28 |
2022-12-01 |
Lyell Immunopharma, Inc. |
Nr4a3-deficient immune cells and uses thereof
|
WO2022256448A2
(en)
|
2021-06-01 |
2022-12-08 |
Artisan Development Labs, Inc. |
Compositions and methods for targeting, editing, or modifying genes
|
WO2022256437A1
(en)
|
2021-06-02 |
2022-12-08 |
Lyell Immunopharma, Inc. |
Nr4a3-deficient immune cells and uses thereof
|
KR102618072B1
(ko)
|
2021-06-15 |
2023-12-28 |
대한민국 |
작물의 개화조절 관련 유전자 교정용 가이드 rna 및 이의 용도
|
EP4370676A2
(en)
|
2021-06-18 |
2024-05-22 |
Artisan Development Labs, Inc. |
Compositions and methods for targeting, editing or modifying human genes
|
WO2023283359A2
(en)
|
2021-07-07 |
2023-01-12 |
Omega Therapeutics, Inc. |
Compositions and methods for modulating secreted frizzled receptor protein 1 (sfrp1) gene expression
|
KR20230010617A
(ko)
|
2021-07-09 |
2023-01-19 |
주식회사 툴젠 |
산화스트레스 저항성을 갖는 중간엽줄기세포, 이의 제조방법 및 용도
|
AU2022320438A1
(en)
|
2021-07-29 |
2024-02-15 |
Toolgen Incorporated |
Hemocompatible mesenchymal stem cells, preparation method therefor and use thereof
|
CN113584134B
(zh)
*
|
2021-09-06 |
2024-01-30 |
青岛金斯达生物技术有限公司 |
一种基于CRISPR-Cas9的等温核酸检测***及其方法和应用
|
WO2023039586A1
(en)
|
2021-09-10 |
2023-03-16 |
Agilent Technologies, Inc. |
Guide rnas with chemical modification for prime editing
|
CN118119702A
(zh)
|
2021-10-14 |
2024-05-31 |
隆萨销售股份有限公司 |
用于细胞外囊泡产生的经修饰的生产者细胞
|
CN118251491A
(zh)
|
2021-10-28 |
2024-06-25 |
瑞泽恩制药公司 |
用于敲除C5的CRISPR/Cas相关方法及组合物
|
IL312452A
(en)
|
2021-11-01 |
2024-06-01 |
Tome Biosciences Inc |
A transformant has a single structure for the simultaneous transfer of a gene editing mechanism and a nucleic acid cargo
|
WO2023108047A1
(en)
|
2021-12-08 |
2023-06-15 |
Regeneron Pharmaceuticals, Inc. |
Mutant myocilin disease model and uses thereof
|
WO2023122764A1
(en)
|
2021-12-22 |
2023-06-29 |
Tome Biosciences, Inc. |
Co-delivery of a gene editor construct and a donor template
|
CA3240593A1
(en)
|
2021-12-23 |
2023-06-29 |
Joel D. Richter |
Therapeutic treatment for fragile x-associated disorder
|
WO2023129974A1
(en)
|
2021-12-29 |
2023-07-06 |
Bristol-Myers Squibb Company |
Generation of landing pad cell lines
|
WO2023150181A1
(en)
|
2022-02-01 |
2023-08-10 |
President And Fellows Of Harvard College |
Methods and compositions for treating cancer
|
WO2023150620A1
(en)
|
2022-02-02 |
2023-08-10 |
Regeneron Pharmaceuticals, Inc. |
Crispr-mediated transgene insertion in neonatal cells
|
WO2023167882A1
(en)
|
2022-03-01 |
2023-09-07 |
Artisan Development Labs, Inc. |
Composition and methods for transgene insertion
|
CN114410609B
(zh)
*
|
2022-03-29 |
2022-07-12 |
舜丰生物科技(海南)有限公司 |
一种活性提高的Cas蛋白以及应用
|
WO2023205744A1
(en)
|
2022-04-20 |
2023-10-26 |
Tome Biosciences, Inc. |
Programmable gene insertion compositions
|
WO2023205844A1
(en)
*
|
2022-04-26 |
2023-11-02 |
Peter Maccallum Cancer Institute |
Nucleic acids and uses thereof
|
WO2023212677A2
(en)
|
2022-04-29 |
2023-11-02 |
Regeneron Pharmaceuticals, Inc. |
Identification of tissue-specific extragenic safe harbors for gene therapy approaches
|
WO2023215831A1
(en)
|
2022-05-04 |
2023-11-09 |
Tome Biosciences, Inc. |
Guide rna compositions for programmable gene insertion
|
WO2023220603A1
(en)
|
2022-05-09 |
2023-11-16 |
Regeneron Pharmaceuticals, Inc. |
Vectors and methods for in vivo antibody production
|
WO2023225665A1
(en)
|
2022-05-19 |
2023-11-23 |
Lyell Immunopharma, Inc. |
Polynucleotides targeting nr4a3 and uses thereof
|
WO2023225670A2
(en)
|
2022-05-20 |
2023-11-23 |
Tome Biosciences, Inc. |
Ex vivo programmable gene insertion
|
WO2023225410A2
(en)
|
2022-05-20 |
2023-11-23 |
Artisan Development Labs, Inc. |
Systems and methods for assessing risk of genome editing events
|
WO2023230549A2
(en)
|
2022-05-25 |
2023-11-30 |
Flagship Pioneering Innovations Vii, Llc |
Compositions and methods for modulation of tumor suppressors and oncogenes
|
WO2023230566A2
(en)
|
2022-05-25 |
2023-11-30 |
Flagship Pioneering Innovations Vii, Llc |
Compositions and methods for modulating cytokines
|
WO2023230578A2
(en)
|
2022-05-25 |
2023-11-30 |
Flagship Pioneering Innovations Vii, Llc |
Compositions and methods for modulating circulating factors
|
WO2023230570A2
(en)
|
2022-05-25 |
2023-11-30 |
Flagship Pioneering Innovations Vii, Llc |
Compositions and methods for modulating genetic drivers
|
WO2023230573A2
(en)
|
2022-05-25 |
2023-11-30 |
Flagship Pioneering Innovations Vii, Llc |
Compositions and methods for modulation of immune responses
|
WO2023235725A2
(en)
|
2022-05-31 |
2023-12-07 |
Regeneron Pharmaceuticals, Inc. |
Crispr-based therapeutics for c9orf72 repeat expansion disease
|
WO2023235726A2
(en)
|
2022-05-31 |
2023-12-07 |
Regeneron Pharmaceuticals, Inc. |
Crispr interference therapeutics for c9orf72 repeat expansion disease
|
WO2024006955A1
(en)
|
2022-06-29 |
2024-01-04 |
Intellia Therapeutics, Inc. |
Engineered t cells
|
WO2024005863A1
(en)
|
2022-06-30 |
2024-01-04 |
Inari Agriculture Technology, Inc. |
Compositions, systems, and methods for genome editing
|
WO2024005864A1
(en)
|
2022-06-30 |
2024-01-04 |
Inari Agriculture Technology, Inc. |
Compositions, systems, and methods for genome editing
|
EP4299739A1
(en)
|
2022-06-30 |
2024-01-03 |
Inari Agriculture Technology, Inc. |
Compositions, systems, and methods for genome editing
|
EP4299733A1
(en)
|
2022-06-30 |
2024-01-03 |
Inari Agriculture Technology, Inc. |
Compositions, systems, and methods for genome editing
|
WO2024020587A2
(en)
|
2022-07-22 |
2024-01-25 |
Tome Biosciences, Inc. |
Pleiopluripotent stem cell programmable gene insertion
|
WO2024026474A1
(en)
|
2022-07-29 |
2024-02-01 |
Regeneron Pharmaceuticals, Inc. |
Compositions and methods for transferrin receptor (tfr)-mediated delivery to the brain and muscle
|
WO2024031053A1
(en)
|
2022-08-05 |
2024-02-08 |
Regeneron Pharmaceuticals, Inc. |
Aggregation-resistant variants of tdp-43
|
CN115386597A
(zh)
*
|
2022-09-19 |
2022-11-25 |
国家纳米科学中心 |
一种提高基因载体转染效率和/或转染精度的转染辅助试剂及其应用
|
WO2024064952A1
(en)
|
2022-09-23 |
2024-03-28 |
Lyell Immunopharma, Inc. |
Methods for culturing nr4a-deficient cells overexpressing c-jun
|
WO2024064958A1
(en)
|
2022-09-23 |
2024-03-28 |
Lyell Immunopharma, Inc. |
Methods for culturing nr4a-deficient cells
|
WO2024073606A1
(en)
|
2022-09-28 |
2024-04-04 |
Regeneron Pharmaceuticals, Inc. |
Antibody resistant modified receptors to enhance cell-based therapies
|
WO2024077174A1
(en)
|
2022-10-05 |
2024-04-11 |
Lyell Immunopharma, Inc. |
Methods for culturing nr4a-deficient cells
|
US20240182561A1
(en)
|
2022-11-04 |
2024-06-06 |
Regeneron Pharmaceuticals, Inc. |
Calcium voltage-gated channel auxiliary subunit gamma 1 (cacng1) binding proteins and cacng1-mediated delivery to skeletal muscle
|
WO2024102434A1
(en)
|
2022-11-10 |
2024-05-16 |
Senda Biosciences, Inc. |
Rna compositions comprising lipid nanoparticles or lipid reconstructed natural messenger packs
|
US20240173426A1
(en)
|
2022-11-14 |
2024-05-30 |
Regeneron Pharmaceuticals, Inc. |
Compositions and methods for fibroblast growth factor receptor 3-mediated delivery to astrocytes
|
WO2024138194A1
(en)
|
2022-12-22 |
2024-06-27 |
Tome Biosciences, Inc. |
Platforms, compositions, and methods for in vivo programmable gene insertion
|